Figure 1.
MiR-145 is lowly expressed in HCC and low expression of it indicates poor prognosis of patients. (A) Expression of miR-145 in HCC tissues and corresponding paracancerous tissues according to the qRT-PCR assay. (B) Expression of miR-145 in HCC patients at different TNM stages. (C) Expression of miR-145 in HCC patients with different lymph node metastasis. (D) Relationship between miR-145 expression in tissues and 5-year OS of the HCC patients.
Note: *** indicates P<0.001.
Abbreviations: miR, microRNA; TNM, tumor node metastasis.